What is the LIFE-BTK Study? | Abbott
CARDIOVASCULAR
hamburger

Abbott is investigating a new treatment option for patients with critical limb ischemia (CLI)

Critical limb ischemia (CLI) is a severe form of peripheral artery disease (PAD).

The LIFE-BTK (“below the knee”) study is evaluating Esprit™ BTK, a medical device manufactured by Abbott. It is called a drug-eluting resorbable scaffold because it is placed in the artery immediately after a balloon angioplasty, supporting and preventing the vessel from reclosing. Once implanted, the scaffold releases a drug over a few months that promotes healing and keeps the artery open. The scaffold is naturally resorbed into the body over time, like dissolving stitches, and will be gone from your body in about 3 years, leaving only a healed artery behind.

The procedure is similar to the technique required to unblock arteries in the heart, but instead it is used below the knee to restore blood flow to the foot, with the goal of preventing amputation.

Scaffolding


The purpose of the LIFE-BTK study is to find out whether this new treatment option could offer greater benefits than the current option of balloon angioplasty alone to open the blocked arteries in the leg and to keep the arteries open to prevent possible amputation.

Hear why Dr. Bajakian, Director, CLI Program at Columbia, feels it’s important to be a physician participating in clinical studies.

CAUTION: Esprit™ BTK is an Investigational Device. Limited by Federal (USA) law for investigational use only.

Illustrations are artist’s representations only and should not be considered as engineering drawings or photographs. Photos on file at Abbott.

Information contained herein for DISTRIBUTION to LIFE-BTK clinical trial sites ONLY.

Abbott
3200 Lakeside Dr., Santa Clara, CA 95054 USA. Tel: 1.800.227.9902

™ Indicates a trademark of the Abbott Group of Companies.

©2022 Abbott. All rights reserved. CL1015408

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.